DNAPrint Genomics, Inc.
DNAG
$0.00
$0.000.00%
OTC PK
| 09/30/2007 | 06/30/2007 | ||||
|---|---|---|---|---|---|
| Revenue | -52.29% | -31.95% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -52.29% | -31.95% | |||
| Cost of Revenue | -40.15% | -23.98% | |||
| Gross Profit | -107.70% | -54.00% | |||
| SG&A Expenses | 7.59% | -2.27% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.25% | -9.94% | |||
| Operating Income | -14.14% | -0.74% | |||
| Income Before Tax | -10.86% | -158.76% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -10.86% | -158.76% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -10.86% | -158.76% | |||
| EBIT | -14.14% | -0.74% | |||
| EBITDA | -15.80% | -0.60% | |||
| EPS Basic | 0.00% | -151.72% | |||
| Normalized Basic EPS | 0.00% | 20.83% | |||
| EPS Diluted | 0.00% | -176.92% | |||
| Normalized Diluted EPS | 0.00% | -18.75% | |||
| Average Basic Shares Outstanding | 11.77% | 13.80% | |||
| Average Diluted Shares Outstanding | 11.77% | -23.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||